SG11201906731XA - Media and methods for enhancing the survival and proliferation of stem cells - Google Patents

Media and methods for enhancing the survival and proliferation of stem cells

Info

Publication number
SG11201906731XA
SG11201906731XA SG11201906731XA SG11201906731XA SG11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA SG 11201906731X A SG11201906731X A SG 11201906731XA
Authority
SG
Singapore
Prior art keywords
vancouver
suite
international
british columbia
street
Prior art date
Application number
SG11201906731XA
Other languages
English (en)
Inventor
Adam Hirst
Melanie Kardel
Wing Chang
Michael Hiatt
Eric Jervis
Arwen Hunter
Original Assignee
Stemcell Tech Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemcell Tech Canada Inc filed Critical Stemcell Tech Canada Inc
Publication of SG11201906731XA publication Critical patent/SG11201906731XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201906731XA 2017-01-23 2018-01-23 Media and methods for enhancing the survival and proliferation of stem cells SG11201906731XA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762449413P 2017-01-23 2017-01-23
US201762518776P 2017-06-13 2017-06-13
US201762608875P 2017-12-21 2017-12-21
PCT/CA2018/050076 WO2018132926A1 (en) 2017-01-23 2018-01-23 Media and methods for enhancing the survival and proliferation of stem cells

Publications (1)

Publication Number Publication Date
SG11201906731XA true SG11201906731XA (en) 2019-08-27

Family

ID=62907538

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201906731XA SG11201906731XA (en) 2017-01-23 2018-01-23 Media and methods for enhancing the survival and proliferation of stem cells

Country Status (9)

Country Link
US (2) US11697796B2 (zh)
EP (2) EP3571290B1 (zh)
JP (1) JP7049347B2 (zh)
CN (1) CN110462025B (zh)
AU (1) AU2018209127B2 (zh)
CA (1) CA3051141C (zh)
IL (1) IL268194B (zh)
SG (1) SG11201906731XA (zh)
WO (1) WO2018132926A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7049347B2 (ja) 2017-01-23 2022-04-06 ステムセル テクノロジーズ カナダ インコーポレイテッド 幹細胞の生存および増殖を高めるための培地および方法
CN111808797A (zh) * 2020-07-28 2020-10-23 湖南赛诺生物科技股份有限公司 Necrostatin-1的应用及促进新生猪胰岛细胞成熟的制剂
AU2021337864A1 (en) 2020-09-02 2023-05-04 Yztherapeutic Performance Ltd. Cellular composition for treatment of diseases, disorders or conditions and method of use
WO2022114724A1 (ko) * 2020-11-27 2022-06-02 (주)엑셀세라퓨틱스 고효율 및 고순도 엑소좀 생산용 배지 조성물
US20240117313A1 (en) * 2021-02-15 2024-04-11 Toppan Inc. Method for producing three-dimensional tissue body and method for promoting differentiation of adipose-derived stem cells
CN116814532A (zh) * 2023-07-10 2023-09-29 上海迈邦生物科技有限公司 一种用于哺乳动物细胞培养基的脂类复合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101044235B (zh) 2004-09-08 2013-01-02 威斯康星校友研究基金会 胚胎干细胞的培养基和培养
AU2007205522B2 (en) * 2006-01-13 2011-08-11 Two Cells Co., Ltd. Additive for culture medium for use in serum-free culture of animal cell, kit, and use of the additive or kit
US8241908B2 (en) 2006-05-16 2012-08-14 Becton, Dickinson And Company Extracellular matrix coated surface for culturing cells
GB0613756D0 (en) 2006-07-12 2006-08-23 Univ Sheffield Cell culture medium
FI20096288A0 (fi) 2009-12-04 2009-12-04 Kristiina Rajala Formulations and methods for culturing stem cells
EP2521628B1 (en) 2010-01-06 2018-02-28 Ervin Industries, Inc. Frangible, ceramic-metal composite projectiles and methods of making the same
JP6148429B2 (ja) * 2011-01-31 2017-06-14 協和発酵バイオ株式会社 ヒト多能性幹細胞の培養方法
US8497124B2 (en) 2011-12-05 2013-07-30 Factor Bioscience Inc. Methods and products for reprogramming cells to a less differentiated state
WO2014192938A1 (ja) 2013-05-30 2014-12-04 味の素株式会社 幹細胞の培養用培地
US20160230143A1 (en) * 2013-09-19 2016-08-11 The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Chemically defined culture medium for stem cell maintenance and differentiation
CA2981277A1 (en) * 2015-03-30 2016-10-06 Ajinomoto Co., Inc. Human serum albumin-containing culture medium for growth of neural stem cells
JP7049347B2 (ja) 2017-01-23 2022-04-06 ステムセル テクノロジーズ カナダ インコーポレイテッド 幹細胞の生存および増殖を高めるための培地および方法

Also Published As

Publication number Publication date
JP7049347B2 (ja) 2022-04-06
CN110462025A (zh) 2019-11-15
CA3051141C (en) 2021-06-22
CN110462025B (zh) 2023-11-21
IL268194B (en) 2022-05-01
WO2018132926A1 (en) 2018-07-26
EP3571290B1 (en) 2024-04-10
EP4361256A2 (en) 2024-05-01
AU2018209127A1 (en) 2019-08-08
US20230250392A1 (en) 2023-08-10
JP2020505038A (ja) 2020-02-20
US20200017825A1 (en) 2020-01-16
US11697796B2 (en) 2023-07-11
AU2018209127B2 (en) 2021-10-21
IL268194A (en) 2019-09-26
EP3571290A1 (en) 2019-11-27
EP3571290A4 (en) 2020-10-28
CA3051141A1 (en) 2018-07-26

Similar Documents

Publication Publication Date Title
SG11201906731XA (en) Media and methods for enhancing the survival and proliferation of stem cells
SG11201909710XA (en) Indole ahr inhibitors and uses thereof
SG11201909541WA (en) Chimeric antibody/t-cell receptor constructs and uses thereof
SG11201806758VA (en) Vcn enhancer compositions and methods of using the same
SG11201808783XA (en) Cd80 variant immunomodulatory proteins and uses thereof
SG11201906883SA (en) Methods for the administration of certain vmat2 inhibitors
SG11201900772YA (en) Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
SG11201803983UA (en) Transformable tagging compositions, methods, and processes incorporating same
SG11201909931PA (en) Oligomeric particle reagents and methods of use thereof
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201808799SA (en) Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors
SG11201909949XA (en) Targeted immunotolerance
SG11201806398YA (en) Optimized factor viii genes
SG11201809710RA (en) Genetically engineered cells and methods of making the same
SG11201807401RA (en) Therapeutic membrane vesicles
SG11201806650VA (en) Systems and methods for providing a personal distributed ledger
SG11201807608VA (en) Dynamically convey information of demodulation reference signal and phase noise compensation reference signal
SG11201907769XA (en) Cd80 variant immunomodulatory proteins and uses thereof
SG11201407417VA (en) Encoding and reconstruction of residual data based on support information
SG11201906238TA (en) Split sector level sweep using beamforming refinement frames
CA3015078A1 (en) Extended synchronization signal for symbol index detection
SG11201408536WA (en) METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF
SG11201900609PA (en) Method and system for providing buffer solutions
SG11201909419XA (en) Hydrogel for cell culture and biomedical applications
SG11201900231RA (en) Culture media for culturing pluripotent stem cells in suspension